NO986088D0 - Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi - Google Patents
Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisiInfo
- Publication number
- NO986088D0 NO986088D0 NO986088A NO986088A NO986088D0 NO 986088 D0 NO986088 D0 NO 986088D0 NO 986088 A NO986088 A NO 986088A NO 986088 A NO986088 A NO 986088A NO 986088 D0 NO986088 D0 NO 986088D0
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- antigen binding
- specificity
- ability
- binding structures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96810421 | 1996-06-24 | ||
PCT/EP1997/003253 WO1997049809A1 (en) | 1996-06-24 | 1997-06-20 | Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
Publications (3)
Publication Number | Publication Date |
---|---|
NO986088D0 true NO986088D0 (no) | 1998-12-23 |
NO986088L NO986088L (no) | 1999-02-24 |
NO327947B1 NO327947B1 (no) | 2009-10-26 |
Family
ID=8225636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19986088A NO327947B1 (no) | 1996-06-24 | 1998-12-23 | Polypeptider som kan danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, DNA-sekvenser, fremgangsmater for seleksjon av rekombinante polypeptider som kan danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, anti-Rhesus D-antistoffer, framgangsmate for fremstilling av fullstendige anti-Rhesus D-antistoffer, farmasoytisk preparat samt diagnostisk preparat for Rhesus D-type bestemmelse |
Country Status (23)
Country | Link |
---|---|
US (3) | US7038020B1 (no) |
EP (1) | EP0920509B1 (no) |
JP (1) | JP3841360B2 (no) |
KR (1) | KR100361449B1 (no) |
AT (1) | ATE272116T1 (no) |
AU (1) | AU722127B2 (no) |
BG (1) | BG64534B1 (no) |
BR (1) | BR9709958A (no) |
CA (1) | CA2258494C (no) |
CZ (1) | CZ296807B6 (no) |
DE (1) | DE69730031T2 (no) |
DK (1) | DK0920509T3 (no) |
ES (1) | ES2224255T3 (no) |
HU (1) | HUP9902605A3 (no) |
IL (1) | IL127595A (no) |
IS (1) | IS2220B (no) |
NO (1) | NO327947B1 (no) |
NZ (1) | NZ333329A (no) |
PL (1) | PL186019B1 (no) |
RU (1) | RU2204602C2 (no) |
SK (1) | SK284879B6 (no) |
TR (1) | TR199802692T2 (no) |
WO (1) | WO1997049809A1 (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029583A2 (en) * | 1998-11-19 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Immunoglobulin superfamily proteins |
EP1106625A1 (en) * | 1999-11-17 | 2001-06-13 | ZLB Bioplasma AG | Rhesus D specific peptide sequences |
FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
CA2406236C (en) | 2000-04-17 | 2013-02-19 | Dyax Corp. | Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
WO2002046435A2 (en) * | 2000-12-05 | 2002-06-13 | Alexion Pharmaceuticals, Inc. | Engineered plasmids and their use for in situ production of genes |
PT2316940E (pt) | 2000-12-18 | 2013-10-16 | Dyax Corp | Bibliotecas orientadas de pacotes genéticos |
AU2016225923B2 (en) * | 2001-04-17 | 2018-07-05 | Takeda Pharmaceutical Company Limited | Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
EP1787126B1 (en) | 2004-07-20 | 2009-09-23 | Symphogen A/S | A procedure for characterization of a polyclonal cell line |
CA2574062A1 (en) | 2004-07-20 | 2006-01-26 | Symphogen A/S | Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
GB0706558D0 (en) * | 2007-04-03 | 2007-05-09 | Common Services Agency For The | Diagnostic assay |
US8691730B2 (en) | 2007-09-14 | 2014-04-08 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US20090093004A1 (en) | 2007-10-04 | 2009-04-09 | Symphogen A/S | Potency assay |
WO2009114815A1 (en) | 2008-03-13 | 2009-09-17 | Dyax Corp | Libraries of genetic packages comprising novel hc cdr3 designs |
ES2528963T3 (es) | 2008-04-24 | 2015-02-13 | Dyax Corp. | Bibliotecas de paquetes genéticos que comprenden nuevos diseños de CDR1, CDR2, y CDR3 de HC y nuevos diseños de CDR1, CDR2, y CDR3 de LC |
CN105734678B (zh) | 2010-07-16 | 2019-11-05 | 阿迪马布有限责任公司 | 合成多核苷酸文库 |
US20150284450A1 (en) * | 2012-11-06 | 2015-10-08 | Medimmune, Llc | Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2127434A (en) | 1982-09-17 | 1984-04-11 | Univ London | A human monoclonal antibody against Rhesus D antigen |
GB8925590D0 (en) * | 1989-11-13 | 1990-01-04 | Central Blood Lab Authority | Monoclonal antibodies |
-
1997
- 1997-06-20 KR KR10-1998-0710975A patent/KR100361449B1/ko not_active IP Right Cessation
- 1997-06-20 NZ NZ333329A patent/NZ333329A/xx not_active IP Right Cessation
- 1997-06-20 AT AT97929244T patent/ATE272116T1/de active
- 1997-06-20 CA CA002258494A patent/CA2258494C/en not_active Expired - Fee Related
- 1997-06-20 AU AU33423/97A patent/AU722127B2/en not_active Expired
- 1997-06-20 US US09/147,443 patent/US7038020B1/en not_active Expired - Fee Related
- 1997-06-20 HU HU9902605A patent/HUP9902605A3/hu unknown
- 1997-06-20 PL PL97330794A patent/PL186019B1/pl not_active IP Right Cessation
- 1997-06-20 JP JP50232398A patent/JP3841360B2/ja not_active Expired - Lifetime
- 1997-06-20 DK DK97929244T patent/DK0920509T3/da active
- 1997-06-20 ES ES97929244T patent/ES2224255T3/es not_active Expired - Lifetime
- 1997-06-20 EP EP97929244A patent/EP0920509B1/en not_active Expired - Lifetime
- 1997-06-20 WO PCT/EP1997/003253 patent/WO1997049809A1/en active IP Right Grant
- 1997-06-20 BR BR9709958A patent/BR9709958A/pt not_active Application Discontinuation
- 1997-06-20 TR TR1998/02692T patent/TR199802692T2/xx unknown
- 1997-06-20 IL IL12759597A patent/IL127595A/xx not_active IP Right Cessation
- 1997-06-20 DE DE69730031T patent/DE69730031T2/de not_active Expired - Lifetime
- 1997-06-20 SK SK1761-98A patent/SK284879B6/sk not_active IP Right Cessation
- 1997-06-20 CZ CZ0395998A patent/CZ296807B6/cs not_active IP Right Cessation
- 1997-06-20 RU RU99101121/13A patent/RU2204602C2/ru not_active IP Right Cessation
-
1998
- 1998-12-11 IS IS4922A patent/IS2220B/is unknown
- 1998-12-15 BG BG103016A patent/BG64534B1/bg unknown
- 1998-12-23 NO NO19986088A patent/NO327947B1/no not_active IP Right Cessation
-
2005
- 2005-06-20 US US11/155,775 patent/US7399471B2/en not_active Expired - Fee Related
-
2006
- 2006-01-18 US US11/333,197 patent/US7429647B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO986088D0 (no) | Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi | |
TR199801722T2 (xx) | Peptit imm�nojenler. | |
WO2002072636A3 (en) | Crystals of whole antibodies and fragments thereof and methods for making and using them | |
ATE196314T1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit | |
WO2000037025A3 (en) | Antibodies to truncated vegf-d and uses thereof | |
WO2001093913A3 (en) | T cell receptor fusions and conjugates and methods of use thereof | |
EP0651818A4 (en) | IMMUNOGENIC PEPTIDES, ANTIBODIES AND USES THEREOF IN CONNECTION WITH THE BINDING OF THE CD4 MOLECULE RECEPTOR. | |
WO1998050547A3 (en) | Human toll-like receptor proteins, related reagents and methods | |
DK0970126T3 (da) | Hidtil ukendt fremgangsmåde til fremstillingen af anti-humant antigen-receptorer og anvendelser deraf | |
IL221708A0 (en) | Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response | |
IL138424A (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
ATE132197T1 (de) | Monoklonale antikörper | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
AU6832398A (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
EP1433792A3 (en) | Human receptor proteins, related reagents and methods | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
CA2068222A1 (en) | Monoclonal antibodies | |
DK0845998T3 (da) | Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles | |
ATE360695T1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
HK1048323A1 (en) | Production of mammary secretion antibodies in farmanimals | |
WO1999002564A3 (de) | Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |